Intervention(s) and comparator(s) | Duration of intervention (duration of follow‐up) [days, months, years ...] | Description of participants | Trial period [year to year] | Country | Setting | Ethnic groups [%] | Duration of diabetes [mean/range years (SD), or as reported] | |
Umpierrez 2004a | I: s.c. insulin lispro | Resolution of DKA: mean 10 h (mean hospital stay: 4 d) |
Adults with "uncomplicated" DKA (not stated if type 1 or 2 diabetes) | ‐ | USA | Regional medical centre DKA established in the ED Regular medicine ward, intermediate care unit (step‐down unit) |
African American: 75 | 6.7 (5) |
C: i.v. regular insulin | Resolution of DKA: mean 11 h (mean hospital stay: 4 d) |
Regional medical centre DKA established in the ED ICU |
African American: 80 | 6.9 (4) | ||||
Umpierrez 2004b | I1: s.c. insulin aspart, every hour | Resolution of DKA: mean 10 h (mean hospital stay: 3.4 d) |
Adults with "uncomplicated" DKA (not stated if type 1 or 2 diabetes) | ‐ | USA | Regional medical centre DKA established in the ED General medical ward or step‐down unit |
‐ | ‐ |
I2: s.c. insulin aspart, every 2 h | Resolution of DKA: mean 10.7 h (mean hospital stay: 3.9 d) |
|||||||
C: i.v. regular insulin | Resolution of DKA: mean 11 h (mean hospital stay: 4.5 d) |
Regional medical centre
DKA established in the ED ICU |
||||||
Della Manna 2005 | I: s.c. insulin lispro | Resolution of metabolic acidosis/ketosis: "in the next 6 h interval" (later than after i.v. regular insulin) Resolution of DKA: 12 h after capillary glucose < 250 mg/dL (mean hospital stay 2‐3 d) |
Children and adolescents with DKA | 2001 to 2003 | Brazil | University children's hospital, 57 DKA episodes treated in ED, 3 DKA episodes treated in ICU | ‐ | ‐ |
C: i.v. regular insulin | Resolution of metabolic acidosis/ketosis: 6 h after capillary glucose ≤ 250 mg/dL Resolution of DKA: 12 h after capillary glucose < 250 mg/dL (mean hospital stay 2‐3 d) |
|||||||
Ersöz 2006 | I: s.c. insulin lispro | Resolution of DKA: no data (hospital stay: no data) | Adults with mild or moderate DKA (not stated if type 1 or 2 diabetes) | ‐ | Turkey | ‐ | ‐ | 3.9 (4.5) |
C: i.v. regular insulin | 4.5 (4.3) | |||||||
Karoli 2011 | I: s.c. insulin lispro | Resolution of DKA: mean 12 h (mean hospital stay 6 d) |
Adults with mild to moderate DKA (> 50% of participants had type 2 diabetes) | 2009 to 2010 | India | Teaching hospital, ED | ‐ | 6.4 (5) |
C: i.v. regular insulin | Resolution of DKA: mean 11 h (mean hospital stay 6.6 d) |
Teaching hospital, ICU | 6.8 (4) | |||||
‐ denotes not reported C: comparator; d: days; DKA: diabetic ketoacidosis; ED: emergency department; h: hours; I: intervention; ICU: intensive care unit; i.v.: intravenous; s.c.: subcutaneous; SD: standard deviation |